3.71% 0.0093

Pre-mercato: .26

AEON Biopharma Inc. (AEON)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

AEON Biopharma Inc. Borsa (AEON) Ultime notizie

AEON Biopharma Inc. (AEON)

AEON Biopharma Inc. Borsa (AEON) Ultime notizie

AEON|Aeon Biopharma Inc|Price:0.257|Chg%:+0.006 - TradingKey

Aeon Biopharma Inc (AEON) Valuation: PE, PB & Fair Value Analysis - TradingKey

Aeon Biopharma Inc (AEON) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Aeon Biopharma Inc (AEON) Income Statement - TradingKey

Aeon Biopharma Inc (AEON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Bitget Launchpool adds AEON (AEON) with 1.1M in Token Rewards - GlobeNewswire Inc.

Aeon Biopharma Inc (AEON) Balance Sheet - TradingKey

Aeon Biopharma Inc (AEON) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Aeon Biopharma Inc (AEON) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Aeon Biopharma Inc (AEON) Cash Flow - TradingKey

Aeon Biopharma Inc (AEON) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

AEON Biopharma, Inc. Revenue Breakdown – BOATS:AEON - TradingView

Aeon Biopharma Inc (AEON) Institutional Confidence - TradingKey

Aeon Biopharma Inc (AEON) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

AEON|Aeon Biopharma Inc|Price:0.228|Chg%:-0.023 - TradingKey

AEON Biopharma boosts liquidity with additional share sale - TipRanks

AEON Biopharma says underwriters fully exercise milestone warrant over-allotment option for 6,403,290 shares - Bitget

Stonepine Capital group discloses 9.9% AEON Biopharma (AEON) ownership via stock and warrants - Stock Titan

AEON Biopharma Inc. (AEON) Hovers Near Support as Bearish Pressure PersistsMutual Fund Flow - dars.gov.et

NFA- today's 8K - Moomoo

AEON Biopharma (NYSE American: AEON) prices $13.75M stock and milestone warrant sale - Stock Titan

AEON Biopharma (NYSE American: AEON) sells stock and milestone-tied warrants - Stock Titan

AEON BiopharmaOffering Includes 42.69 Mln - Moomoo

AEON Biopharma Announces Pricing of Upsized $13.75 Million Public Offering with Accompanying Milestone Warrants Providing Potential for Additional Future Funding - The Manila Times

AEON Biopharma Could Raise $29.6M More Through Warrants - Stock Titan

AEON Biopharma, Inc. SEC Filing (Jul 14, 2026) - Stock Titan

AEON Biopharma (AEON) Slides 10% Towards Key Support as Selling Pressure IntensifiesFibonacci Time Zone - dars.gov.et

AEON Biopharma (NASDAQ: AEON) revises S-1 filing fee table for milestone warrants - Stock Titan

AEON Biopharma Offering 17.5M Shrs or Pre-Funded Warrants Along With Two-Year and Five-Year Milestone Warrants - Moomoo

Form S-1 Aeon Biopharma Inc For: 8 July By Investing.com - Investing.com Nigeria

AEON Biopharma (AEON) files S-1 for $11M stock sale plus milestone warrants - Stock Titan

AEON Biopharma Q4 2025 Earnings: Wider-Than-Expected Loss Underscores Pre-Revenue ChallengesQuarterly Financial Update - dars.gov.et

AEON Q4 2025 Earnings: Wider Loss Misses Estimates Amid Pre-Revenue StageDownward Estimate Revision - dars.gov.et

AEONAEON Biopharma Inc Latest SEC Filings - Finviz

Price to book forward of AEON Biopharma, Inc. – AMEX:AEON - TradingView

Price to sales forward of AEON Biopharma, Inc. – AMEX:AEON - TradingView

Enterprise value to revenue forward of AEON Biopharma, Inc. – AMEX:AEON - TradingView

AEON Biopharma, Inc. Class A Actuals & Estimates (AMEX:AEON) - TradingView

AEON Forecast — Price Target — Prediction for 2027 - TradingView

Form 4 Aeon Biopharma Inc For: 22 June By Investing.com - Investing.com Nigeria

[Form 4] AEON Biopharma, Inc. Insider Trading Activity - Stock Titan

AEON Biopharma (AEON) grants 222,684 RSUs to director Palmisano - Stock Titan

Director at AEON Biopharma (AEON) granted 222,684 RSUs - Stock Titan

AEON Biopharma (AEON) director awarded 222,684 RSUs in equity grant - Stock Titan

Director Carter granted 222,684 RSUs at AEON Biopharma (AEON) - Stock Titan

AEON Biopharma Inc. (AEON) Edges Higher with Resilience Near Key Support LevelsSymmetrical Triangle - dars.gov.et

AEON BIOPHARMA INC (AEON) Stock Chart - ChartMill

AEON Biopharma shareholders approve directors and auditor slate - TipRanks

Aeon Biopharma Inc (AEON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

AEON Biopharma, Inc. Elects Each of Marc Forth and Seongsoo Park as Class III Directors of the Company's Board of Directors - marketscreener.com

AEON Biopharma (NYSE: AEON) investors back Class III board slate and KPMG - Stock Titan

Simile a AEON